|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
How We Make Better Brands and Brands Better
This video below is a fractal - a simple geometric formula. Repeated again and again it creates an overwhelming profusion of complex patterns. It is the process inherent in the formation of snowflakes, leaves, clouds, continents, consumer behaviour, brands and complex cultures. It is the mathematics of creation. But in reality things never appear that simple when you are part of the emerging form. Just as fish cannot see the water in which they swim, being on the inside of the constantly emerging brand can seem overwhelmingly complex. At QuantumSteps we use well proven experimental psychosocial, cognitive and psychodynamic models to inform what change is needed and how that change occurs. We include everyone with something to say - inside and outside the organisation . By doing so we deliver deep commercial yet human insights that have the longevity and power to make brands better. We are the Fractal Mathematicians of Corporate Brand Growth, Innovation and Development. Our approach works because our approach is simplicity itself. The site is a journey through that thinking - start with a trip from simplicity to complexity that QuantumSteps has prepared through the fractal below:
Founded in 1996 QuantumSteps' unique 'whole business' approach to the delivery of superior research, insight and total Brand Development has proven itself in the global market place. In the past 10 years our cutting edge technology has provided solutions across a vast variety of markets and categories:
In November 2003 we won the coveted Market Research Society David Winton Award from the MRS for our paper on Theory and Practice in the Large Group. In 2006 we began lecturing in Business Leadership at the Warwick University Business School with RDI, and provided a lauded new course to train and immerse Marketers and Researchers in effective breakthrough Consumer Contact and Insight Skills first [piloted with Unilever in 2000/1 and subsequently at GlaxoSmithKline in 2006/7.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||